Pyridiazinone derivatives for the treatment of tumours

US8173653B2 · kind B2 · utility

Assignee

• MERCK PATENT GESELLSCHAFT MIT BESHRANK TER HAFTUNG · DE

Inventors

• Dieter Dorsch · Ober-Ramstadt, DE
• Oliver Schadt · Rodenbach, DE
• Andree Blaukat · Heilbad Heiligenstadt, DE

Key dates

• Filing date: Nov 7, 2006
• Grant date: May 8, 2012
• Expiry date: Jul 24, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/06
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the formula (I), in which R1, R2 and R3 have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumors.